TransMedics Group Inc. logo

TransMedics Group Inc.

TMDX | NASDAQ
Chart Builder DCF Calculator
$87.29
+$0.87 (+1.01%)
At close: Sep 21, 2026, 4:00 PM ET
$87.48
+$0.19 (+0.22%)
Pre-market: Sep 22, 2026, 4:01 AM ET

Market Data

Market Cap
$2.99B
Enterprise Value
$3.41B
Beta
1.88
Average Volume
1.2M
Shares Outstanding (Diluted)
40.71M
Shares Change YoY
0.37%
Institutional Ownership
N/A
Exchange
NASDAQ
ISIN
US89377M1099

Price Performance

Price Change 1M
-7.2%
Price Change 3M
18.2%
Price Change 6M
-17.0%
Price Change YTD
-28.9%
Price Change 1Y
-30.3%
Price Change 3Y
57.6%
Price Change 5Y
178.3%
1M CAGR (ann.)
7.7%
1Y CAGR (ann.)
-27.9%
5Y CAGR (ann.)
22.2%
All-Time CAGR
20.1%

Valuation

PE Ratio
22.61
Forward PE
32.70
PEG Ratio
0.18
Forward PEG
0.36
PS Ratio
4.51
Forward PS
3.40
PB Ratio
5.82
P/FCF Ratio
45.08
P/Adj. FCF Ratio
151.78
P/OCF Ratio
20.68
EV/Sales
5.10
EV/EBIT
36.38
EV/EBITDA
28.44
EV/FCF
50.99
Earnings Yield
4.4%
FCF Yield
2.2%
Adj. FCF Yield
0.7%

Financial Health

Net Debt
$44.97M
Total Debt
$867.72M
Cash & Short-Term Investments
$472.68M
Total Assets
$1.46B
Current Ratio
6.62
Quick Ratio
6.07
Debt / Equity Ratio
1.67
Debt / EBITDA
7.23
Debt / FCF
12.97
OCF / Debt
0.20
Interest Coverage
3.84
Altman Z-Score
2.77
Piotroski F-Score
4

Margins & Profitability

Gross Profit Margin
58.7%
Operating Profit Margin
12.2%
EBITDA Margin
17.9%
Net Profit Margin
22.7%
FCF Margin
10.0%
Adj. FCF Margin
3.0%
SBC / Revenue
5.5%
SBC Impact (per share)
-70.3%

Returns

Return on Assets
10.4%
Return on Equity
33.0%
Return on Invested Capital
5.9%
Return on Capital Employed
6.0%
Return on Tangible Assets
10.4%

Historical Growth (CAGR)

Revenue CAGR 3Y
64.2%
Revenue CAGR 5Y
86.1%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
98.3%
EPS CAGR 5Y
192.9%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
357.1%
FCF CAGR 5Y
73.3%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
13
EPS Growth Next 3Y
7.0%
Revenue Growth Next 3Y
21.0%
Earnings Date
Nov 3, 2026
EPS Estimate (next Q)
$0.27
EPS Growth Est (next Q)
-59.1%
Revenue Est (next Q)
$177.03M
Revenue Growth Est (next Q)
23.1%

Fair Value Estimates

Graham Number
$36.07
Graham Upside
-58.7%
Lynch Fair Value
$96.50
Lynch Upside
10.6%
Price Target
$96.86
Price Target Upside
11.0%

Cash Flow

Operating Cash Flow
$170.46M
Free Cash Flow
$66.92M
Adj. Free Cash Flow
$19.88M
FCF Per Share
$2.29
OCF Per Share
$4.22
OCF/S Ratio
21.8%

Income Statement

Revenue
$668.47M
Gross Profit
$392.35M
Operating Income
$81.61M
EBITDA
$119.98M
Net Income
$151.7M
EPS (Diluted)
$3.86
Revenue / Employee
$744.4K
Profit / Employee
$168.93K
Employees
898

© 2026 bestshares.com. All rights reserved.